These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8582460)

  • 1. Effects of ACE inhibition on endurance exercise haemodynamics in trained subjects with mild hypertension.
    Palatini P; Bongiovi S; Mario L; Mormino P; Raule G; Pessina AC
    Eur J Clin Pharmacol; 1995; 48(6):435-9. PubMed ID: 8582460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
    Nussberger J; Fleck E; Bahrmann H; Delius W; Schultheiss HP; Brunner HR
    Eur Heart J; 1994 Dec; 15 Suppl D():113-22. PubMed ID: 7713100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin-converting enzyme inhibition on left ventricular geometric patterns in patients with essential hypertension.
    De Castro S; Pelliccia F; Cartoni D; Funaro S; Melillo G; Beni S; Magni G; Migliau G; Fedele F
    J Clin Pharmacol; 1996 Dec; 36(12):1141-8. PubMed ID: 9013371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril.
    Kjeldsen SE; Gupta RK; Krause L; Weder AB; Julius S
    Am Heart J; 1992 May; 123(5):1433-8. PubMed ID: 1575171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE inhibition in patients with mild to moderate congestive heart failure.
    Pelliccia F; Borghi A; Ruggeri A; Cianfrocca C; Morgagni GL; Bugiardini R
    Clin Cardiol; 1993 Aug; 16(8):607-12. PubMed ID: 8370193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor.
    Gupta RK; Kjeldsen SE; Krause L; Kneisley J; Posvar E; Weder AB; Julius S
    Clin Pharmacol Ther; 1990 Jul; 48(1):41-9. PubMed ID: 2196144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
    Larochelle P; Haynes B; Maron N; Dugas S
    Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinapril hydrochloride effects on renal function in patients with renal dysfunction and hypertension: a drug-withdrawal study.
    Miller MA; Texter M; Gmerek A; Robbins J; Shurzinske L; Canter D
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):271-5. PubMed ID: 7918140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
    Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
    Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Study Group of Quinapril in Arterial Hypertension. The Steering Committee].
    Ambrosioni E; Brusca A; Caponnetto S; Condorelli M; Corea L; Dal Palù C; Fogari R; Mameli P; Mancia G; Neri Serneri GG
    Minerva Cardioangiol; 1992 Mar; 40(3):85-96. PubMed ID: 1630680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinapril in patients with congestive heart failure: controlled trial versus captopril.
    Acanfora D; Furgi G; Trojano L; Picone C; Iannuzzi GL; Rossi M; Papa A; Rengo C; Rengo F
    Am J Ther; 1997; 4(5-6):181-8. PubMed ID: 10423609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of losartan and its combination with quinapril on the cardiac sympathetic nervous system and neurohormonal status in essential hypertension.
    Sakata K; Yoshida H; Obayashi K; Ishikawa J; Tamekiyo H; Nawada R; Doi O
    J Hypertens; 2002 Jan; 20(1):103-10. PubMed ID: 11791032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinapril in chronic heart failure.
    Northridge DB; Dargie HJ
    Am J Hypertens; 1990 Nov; 3(11):283S-287S. PubMed ID: 2261147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril.
    Frishman WH; Greenberg S
    Am J Hypertens; 1991 Oct; 4(10 Pt 1):827-31. PubMed ID: 1747216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular structure in the forearm and calf after 6 months of angiotensin converting enzyme inhibition in elderly hypertensive subjects with left ventricular hypertrophy.
    Marceau M; Kouamé N; Lacourcière Y; Cléroux J
    J Hypertens; 1998 May; 16(5):673-9. PubMed ID: 9797179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of quinapril in the elderly patient.
    Schnaper HW
    Am J Hypertens; 1990 Nov; 3(11):278S-282S. PubMed ID: 2261146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
    Romero R; Castellote E; Ocón J; Wagner B
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):114-8. PubMed ID: 7564350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.